304 related articles for article (PubMed ID: 24687385)
1. Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial.
Sikjaer T; Rolighed L; Hess A; Fuglsang-Frederiksen A; Mosekilde L; Rejnmark L
Osteoporos Int; 2014 Jun; 25(6):1717-26. PubMed ID: 24687385
[TBL] [Abstract][Full Text] [Related]
2. PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.
Khan AA; Rejnmark L; Rubin M; Schwarz P; Vokes T; Clarke B; Ahmed I; Hofbauer L; Marcocci C; Pagotto U; Palermo A; Eriksen E; Brod M; Markova D; Smith A; Pihl S; Mourya S; Karpf DB; Shu AD
J Clin Endocrinol Metab; 2022 Jan; 107(1):e372-e385. PubMed ID: 34347093
[TBL] [Abstract][Full Text] [Related]
3. PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment.
Sikjaer T; Amstrup AK; Rolighed L; Kjaer SG; Mosekilde L; Rejnmark L
J Bone Miner Res; 2013 Oct; 28(10):2232-43. PubMed ID: 23649554
[TBL] [Abstract][Full Text] [Related]
4. Quality of Life in Hypoparathyroidism.
Vokes TJ
Endocrinol Metab Clin North Am; 2018 Dec; 47(4):855-864. PubMed ID: 30390818
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Hypoparathyroidism by Re-Establishing the Effects of Parathyroid Hormone.
Rejnmark L
Endocrinol Metab (Seoul); 2024 Apr; 39(2):262-266. PubMed ID: 38572533
[TBL] [Abstract][Full Text] [Related]
6. PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Palermo A; Santonati A; Tabacco G; Bosco D; Spada A; Pedone C; Raggiunti B; Doris T; Maggi D; Grimaldi F; Manfrini S; Vescini F
J Clin Endocrinol Metab; 2018 Jan; 103(1):271-280. PubMed ID: 29099939
[TBL] [Abstract][Full Text] [Related]
7. PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life.
Santonati A; Palermo A; Maddaloni E; Bosco D; Spada A; Grimaldi F; Raggiunti B; Volpe R; Manfrini S; Vescini F;
J Clin Endocrinol Metab; 2015 Sep; 100(9):3590-7. PubMed ID: 26196949
[TBL] [Abstract][Full Text] [Related]
8. The effect of PTH(1-84) on quality of life in hypoparathyroidism.
Cusano NE; Rubin MR; McMahon DJ; Irani D; Tulley A; Sliney J; Bilezikian JP
J Clin Endocrinol Metab; 2013 Jun; 98(6):2356-61. PubMed ID: 23596139
[TBL] [Abstract][Full Text] [Related]
9. Does PTH Replacement Therapy Improve Quality of Life in Patients With Chronic Hypoparathyroidism?
Winer KK
J Clin Endocrinol Metab; 2018 Jul; 103(7):2752-2755. PubMed ID: 29897557
[TBL] [Abstract][Full Text] [Related]
10. PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy.
Cusano NE; Rubin MR; McMahon DJ; Irani D; Anderson L; Levy E; Bilezikian JP
J Clin Endocrinol Metab; 2014 Oct; 99(10):3694-9. PubMed ID: 24978675
[TBL] [Abstract][Full Text] [Related]
11. Therapy of hypoparathyroidism with intact parathyroid hormone.
Rubin MR; Sliney J; McMahon DJ; Silverberg SJ; Bilezikian JP
Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
[TBL] [Abstract][Full Text] [Related]
12. PTH replacement therapy of hypoparathyroidism.
Rejnmark L; Sikjaer T; Underbjerg L; Mosekilde L
Osteoporos Int; 2013 May; 24(5):1529-36. PubMed ID: 23184178
[TBL] [Abstract][Full Text] [Related]
13. Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy.
Tabacco G; Tay YD; Cusano NE; Williams J; Omeragic B; Majeed R; Almonte MG; Rubin MR; Bilezikian JP
J Clin Endocrinol Metab; 2019 Jul; 104(7):2748-2756. PubMed ID: 30776291
[TBL] [Abstract][Full Text] [Related]
14. Effects of Supplemental Vitamin D on Muscle Performance and Quality of Life in Graves' Disease: A Randomized Clinical Trial.
Grove-Laugesen D; Cramon PK; Malmstroem S; Ebbehoj E; Watt T; Hansen KW; Rejnmark L
Thyroid; 2020 May; 30(5):661-671. PubMed ID: 31910101
[No Abstract] [Full Text] [Related]
15. PTH 1-34 Replacement Therapy Has Minimal Effect on Quality of Life in Patients With Hypoparathyroidism.
Roszko KL; Hu TY; Guthrie LC; Brillante BA; Smith M; Collins MT; Gafni RI
J Bone Miner Res; 2022 Jan; 37(1):68-77. PubMed ID: 34585778
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism.
Vokes TJ; Mannstadt M; Levine MA; Clarke BL; Lakatos P; Chen K; Piccolo R; Krasner A; Shoback DM; Bilezikian JP
J Clin Endocrinol Metab; 2018 Feb; 103(2):722-731. PubMed ID: 29099947
[TBL] [Abstract][Full Text] [Related]
17. Quality of life in hypoparathyroidism.
Vokes T
Bone; 2019 Mar; 120():542-547. PubMed ID: 30261328
[TBL] [Abstract][Full Text] [Related]
18. Concurrent Hypoparathyroidism Is Associated With Impaired Physical Function and Quality of Life in Hypothyroidism.
Sikjaer T; Moser E; Rolighed L; Underbjerg L; Bislev LS; Mosekilde L; Rejnmark L
J Bone Miner Res; 2016 Jul; 31(7):1440-8. PubMed ID: 26865527
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone therapy for hypoparathyroidism.
Cusano NE; Rubin MR; Bilezikian JP
Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):47-55. PubMed ID: 25617172
[TBL] [Abstract][Full Text] [Related]
20. The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study.
Sikjaer T; Rejnmark L; Rolighed L; Heickendorff L; Mosekilde L;
J Bone Miner Res; 2011 Oct; 26(10):2358-70. PubMed ID: 21773992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
